caa a22 4500 475824423 CHVBK 20180406123827.0 cr unu---uuuuu 170329e20000801xx s 000 0 eng 10.1023/A:1018750822218 doi (NATIONALLICENCE)springer-10.1023/A:1018750822218 Burns Maureen UMASS Memorial Health Care Division of Cardiology, Worcester, MA aut Emerging Concepts in the Diagnosis and Management of Venous Thromboembolism During Pregnancy [Elektronische Daten] [Maureen Burns] Multiple changes in the coagulation system occur during pregnancy and account for the hypercoagulable state of pregnancy. Consequently, pregnant women are five times more likely to experience venous thromboembolism than non-pregnant women. Although the estimated rates of such events are low, venous thromboembolic disease is a leading cause of maternal death. The administration of intravenous or subcutaneous unfractionated heparin is the treatment and prophylaxis of choice. Warfarin is safe and efficacious following delivery, but should be avoided during pregnancy. LMWH is a promising alternative for treatment and prophylaxis, but further clinical experience is required. Kluwer Academic Publishers, 2000 pregnancy nationallicence venous thromboembolism nationallicence unfractionated heparin nationallicence LMWH (low-molecular-weight heparin nationallicence hypercoagulable nationallicence Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 10/1(2000-08-01), 59-68 0929-5305 10:1<59 2000 10 11239 https://doi.org/10.1023/A:1018750822218 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1023/A:1018750822218 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Burns Maureen UMASS Memorial Health Care Division of Cardiology, Worcester, MA aut NATIONALLICENCE 773 0- Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 10/1(2000-08-01), 59-68 0929-5305 10:1<59 2000 10 11239 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer